Attix Pharmaceuticals Recalls Celecoxib API Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling all lots of Celecoxib active pharmaceutical ingredient repackaged between January 2012 and February 2015 due to potential penicillin cross-contamination.
- Product
- Celecoxib active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
- Category
- Drug
- Distribution
- Distributed nationwide